Patents Assigned to ALZINOVA AG
  • Patent number: 9062102
    Abstract: The present invention relates to antibodies and antibody fragments specific for the toxic prefibrillar aggregates of amyloid-beta peptides, and uses thereof, for example in the diagnosis and treatment of amyloid diseases such as Alzheimer's disease and related disorders. The invention further provides methods for the identification of compounds potentially useful for the treatment of an amyloid disease, such as Alzheimer's disease.
    Type: Grant
    Filed: March 7, 2012
    Date of Patent: June 23, 2015
    Assignee: ALZINOVA AG
    Inventors: Anna Sjoblom-Hallen, Anders Sandberg